A project from the American Society of Retina Specialists
Sign in to view content
Analysis of Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) in Patients With nAMD
- Video
- Published 2021
Related
Category: AMD-Neovascular